Editorial: Translation of genetically engineered T cells in cancer immunotherapy

• Ralf-Holger Voss,
• Hakim Echchannaoui,
• Hakim Echchannaoui,
• Hakim Echchannaoui,
• He Huang,
• Shao-An Xue,
• Shao-An Xue

Affiliations

Ralf-Holger Voss

Institute of Immunology, Department of Research Center for Immunotherapy, Laboratory U. Sahin, University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany

Hakim Echchannaoui

Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany

Hakim Echchannaoui

German Cancer Consortium partner site Frankfurt/Mainz, Mainz, Germany

Hakim Echchannaoui

University Cancer Center Mainz, Mainz, Germany

He Huang

Institute of Hematology, Zhejiang University, Hangzhou, China

Shao-An Xue

Surgery, Medical School, Faculty of Medical Sciences, University College London, London, United Kingdom

Shao-An Xue

Genetic Engineering Laboratory, School of Biological & Environmental Engineering, Xi’An University, Xi’An, China